SBC Medical Group Holdings Incorporated (SBC)
NASDAQ: SBC · Real-Time Price · USD
4.000
+0.320 (8.70%)
At close: Aug 21, 2026, 4:00 PM EDT
3.995
-0.005 (-0.13%)
After-hours: Aug 21, 2026, 7:30 PM EDT

SBC Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
49.0350.9946.6139.376.32
Depreciation & Amortization
3.222.683.812.255.93
Loss (Gain) From Sale of Assets
-3.16-3.18-3.3-0.25-1.9
Asset Writedown & Restructuring Costs
--15.060.20.35
Loss (Gain) From Sale of Investments
-1.35-0.933.15-0.220.76
Stock-Based Compensation
0.01-13.02--
Provision & Write-off of Bad Debts
-0.030.3-0.40.370.34
Other Operating Activities
-0.611.34-10.476.6-1.26
Change in Accounts Receivable
4.471.390.62-23-2.86
Change in Inventory
0.27-0.171.12-1.83-0.67
Change in Accounts Payable
5.952.67-8.9112.20.17
Change in Income Taxes
5.56-11.6611.2313.36-8.54
Change in Other Net Operating Assets
-1.11-18.76-50.95-8.391.31
Operating Cash Flow
62.8224.6720.5850.67-0.05
Operating Cash Flow Growth
-19.85%-59.38%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-2.12-2.37-3.41-9.52-24.95
Sale of Property, Plant & Equipment
5.757.48-8.052.24
Cash Acquisitions
-22.94-22.94-4.240.72-6.49
Divestitures
1.02--0.83--
Sale (Purchase) of Intangibles
----1.68-
Investment in Securities
-20.4-21.05-0.331.99-2.65
Other Investing Activities
2.3617.93-1.122.58-0.34
Investing Cash Flow
-36.33-20.97-10.11.79-32.65

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Short-Term Debt Issued
-0.025.4812.310.12
Long-Term Debt Issued
-34.756.6--
Total Debt Issued
34.7534.7712.0912.310.12
Short-Term Debt Repaid
--0.15-0.74-7.71-1.37
Long-Term Debt Repaid
--1.68-0.12-8.73-5.21
Total Debt Repaid
-5.29-1.83-0.86-16.44-6.57
Net Debt Issued (Repaid)
29.4732.9411.23-4.13-6.45
Issuance of Common Stock
0.03-0.030-
Repurchase of Common Stock
-2.58-5---
Other Financing Activities
0.6710.3511.7110.26-1.53
Financing Cash Flow
27.5938.2922.976.14-7.98

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Foreign Exchange Rate Adjustments
-22.51-3.26-11.42-7.31-12.09
Net Cash Flow
31.5738.7322.0251.28-52.77

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
60.722.317.1741.15-24.99
Free Cash Flow Growth
-29.84%-58.26%--
Free Cash Flow Margin
34.65%12.84%8.36%21.26%-14.35%
Free Cash Flow Per Share
0.590.220.180.44-3.14
Levered Free Cash Flow
63.1925.4141.9133.62-
Unlevered Free Cash Flow
63.4125.5141.9333.65-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash Interest Paid
0.350.160.030.050.03
Cash Income Tax Paid
26.2137.1930.2417.8430.82
Change in Working Capital
15.14-26.53-46.88-7.65-10.59
SEC Filings: 10-K · 10-Q